DXCM
Price
$80.51
Change
-$0.25 (-0.31%)
Updated
Sep 5 closing price
Capitalization
31.57B
47 days until earnings call
SNANF
Price
$0.44
Change
-$0.01 (-2.22%)
Updated
Sep 5 closing price
Capitalization
49.77M
Interact to see
Advertisement

DXCM vs SNANF

Header iconDXCM vs SNANF Comparison
Open Charts DXCM vs SNANFBanner chart's image
DexCom
Price$80.51
Change-$0.25 (-0.31%)
Volume$2.72M
Capitalization31.57B
Sona Nanotech
Price$0.44
Change-$0.01 (-2.22%)
Volume$6K
Capitalization49.77M
DXCM vs SNANF Comparison Chart in %
Loading...
DXCM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNANF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DXCM vs. SNANF commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DXCM is a Buy and SNANF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (DXCM: $80.51 vs. SNANF: $0.44)
Brand notoriety: DXCM and SNANF are both not notable
DXCM represents the Medical/Nursing Services, while SNANF is part of the Medical Specialties industry
Current volume relative to the 65-day Moving Average: DXCM: 80% vs. SNANF: 47%
Market capitalization -- DXCM: $31.57B vs. SNANF: $49.77M
DXCM [@Medical/Nursing Services] is valued at $31.57B. SNANF’s [@Medical Specialties] market capitalization is $49.77M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $231.38B to $0. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.66B. The average market capitalization across the [@Medical Specialties] industry is $10.68B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DXCM’s FA Score shows that 1 FA rating(s) are green whileSNANF’s FA Score has 0 green FA rating(s).

  • DXCM’s FA Score: 1 green, 4 red.
  • SNANF’s FA Score: 0 green, 5 red.
According to our system of comparison, DXCM is a better buy in the long-term than SNANF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DXCM’s TA Score shows that 4 TA indicator(s) are bullish while SNANF’s TA Score has 6 bullish TA indicator(s).

  • DXCM’s TA Score: 4 bullish, 5 bearish.
  • SNANF’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, SNANF is a better buy in the short-term than DXCM.

Price Growth

DXCM (@Medical/Nursing Services) experienced а +6.86% price change this week, while SNANF (@Medical Specialties) price change was +3.10% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -0.02%. For the same industry, the average monthly price growth was +4.22%, and the average quarterly price growth was +24.21%.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.01%. For the same industry, the average monthly price growth was +8.25%, and the average quarterly price growth was +13.64%.

Reported Earning Dates

DXCM is expected to report earnings on Oct 23, 2025.

Industries' Descriptions

@Medical/Nursing Services (-0.02% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

@Medical Specialties (+1.01% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DXCM($31.6B) has a higher market cap than SNANF($49.8M). SNANF YTD gains are higher at: 140.712 vs. DXCM (3.523). DXCM has higher annual earnings (EBITDA): 1.04B vs. SNANF (-2.18M). DXCM has more cash in the bank: 2.93B vs. SNANF (731K). SNANF has less debt than DXCM: SNANF (422K) vs DXCM (2.58B). DXCM has higher revenues than SNANF: DXCM (4.3B) vs SNANF (0).
DXCMSNANFDXCM / SNANF
Capitalization31.6B49.8M63,454%
EBITDA1.04B-2.18M-47,723%
Gain YTD3.523140.7123%
P/E Ratio56.70N/A-
Revenue4.3B0-
Total Cash2.93B731K400,684%
Total Debt2.58B422K611,137%
FUNDAMENTALS RATINGS
DXCM vs SNANF: Fundamental Ratings
DXCM
SNANF
OUTLOOK RATING
1..100
1683
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
77
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
41100
PRICE GROWTH RATING
1..100
5336
P/E GROWTH RATING
1..100
22100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SNANF's Valuation (77) in the null industry is in the same range as DXCM (80) in the Medical Specialties industry. This means that SNANF’s stock grew similarly to DXCM’s over the last 12 months.

SNANF's Profit vs Risk Rating (100) in the null industry is in the same range as DXCM (100) in the Medical Specialties industry. This means that SNANF’s stock grew similarly to DXCM’s over the last 12 months.

DXCM's SMR Rating (41) in the Medical Specialties industry is somewhat better than the same rating for SNANF (100) in the null industry. This means that DXCM’s stock grew somewhat faster than SNANF’s over the last 12 months.

SNANF's Price Growth Rating (36) in the null industry is in the same range as DXCM (53) in the Medical Specialties industry. This means that SNANF’s stock grew similarly to DXCM’s over the last 12 months.

DXCM's P/E Growth Rating (22) in the Medical Specialties industry is significantly better than the same rating for SNANF (100) in the null industry. This means that DXCM’s stock grew significantly faster than SNANF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DXCMSNANF
RSI
ODDS (%)
Bullish Trend 1 day ago
68%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
63%
Bearish Trend 1 day ago
71%
Momentum
ODDS (%)
Bearish Trend 1 day ago
67%
Bullish Trend 1 day ago
80%
MACD
ODDS (%)
Bullish Trend 1 day ago
70%
Bullish Trend 1 day ago
79%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
73%
Bearish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
76%
Advances
ODDS (%)
Bullish Trend 3 days ago
71%
Bullish Trend 4 days ago
76%
Declines
ODDS (%)
N/A
Bearish Trend 1 day ago
86%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 1 day ago
73%
Aroon
ODDS (%)
Bearish Trend 1 day ago
68%
Bearish Trend 1 day ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
DXCM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNANF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
TBLU54.340.48
+0.89%
Tortoise Global Water Fund
ARKK75.370.35
+0.47%
ARK Innovation ETF
SCHJ24.940.04
+0.16%
Schwab 1-5 Year Corporate Bond ETF
HSMV36.910.04
+0.12%
First Trust Horizon Managed Vol S/M ETF
AESR19.950.01
+0.03%
Anfield US Equity Sector Rotation ETF

DXCM and

Correlation & Price change

A.I.dvisor indicates that over the last year, DXCM has been loosely correlated with GKOS. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if DXCM jumps, then GKOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DXCM
1D Price
Change %
DXCM100%
-0.31%
GKOS - DXCM
46%
Loosely correlated
+4.22%
VAPO - DXCM
43%
Loosely correlated
N/A
BSX - DXCM
41%
Loosely correlated
-0.07%
PODD - DXCM
41%
Loosely correlated
+0.57%
RMD - DXCM
35%
Loosely correlated
+1.18%
More

SNANF and

Correlation & Price change

A.I.dvisor tells us that SNANF and DXCM have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SNANF and DXCM's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNANF
1D Price
Change %
SNANF100%
-2.06%
DXCM - SNANF
23%
Poorly correlated
-0.31%
EW - SNANF
20%
Poorly correlated
-0.02%
SSMXY - SNANF
5%
Poorly correlated
+2.26%
SKHCF - SNANF
4%
Poorly correlated
N/A
SMMNY - SNANF
3%
Poorly correlated
+0.80%
More